Literature DB >> 22301087

Treating depression and substance use: a randomized controlled trial.

Sarah B Hunter1, Katherine E Watkins, Kimberly A Hepner, Susan M Paddock, Brett A Ewing, Karen C Osilla, Suzanne Perry.   

Abstract

Few integrated substance use and depression treatments have been developed for delivery in outpatient substance abuse treatment settings. To meet the call for more "transportable" interventions, we conducted a pilot study to test a group cognitive-behavioral therapy (CBT) for depression and substance use that was designed for delivery by outpatient substance abuse treatment counselors. Seventy-three outpatient clients were randomized to usual care enhanced with group CBT or usual care alone and assessed at three time points (baseline and 3 and 6 months postbaseline). Our results demonstrated that the treatment was acceptable and feasible for delivery by substance abuse treatment staff despite challenges with recruiting clients. Both depressive symptoms and substance use were reduced by the intervention but were not significantly different from the control group. These results suggest that further research is warranted to enhance the effectiveness of treatment for co-occurring disorders in these settings.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22301087      PMCID: PMC3345298          DOI: 10.1016/j.jsat.2011.12.004

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  59 in total

Review 1.  A comprehensive guide to the application of contingency management procedures in clinical settings.

Authors:  N M Petry
Journal:  Drug Alcohol Depend       Date:  2000-02-01       Impact factor: 4.492

2.  The inventory of drug use consequences (InDUC): test-retest stability and sensitivity to detect change.

Authors:  J Scott Tonigan; William R Miller
Journal:  Psychol Addict Behav       Date:  2002-06

Review 3.  Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature.

Authors:  Morten Hesse
Journal:  BMC Psychiatry       Date:  2009-02-20       Impact factor: 3.630

4.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

5.  Detecting bipolar disorder among treatment-seeking substance abusers.

Authors:  K L Sloan; D Kivlahan; A J Saxon
Journal:  Am J Drug Alcohol Abuse       Date:  2000-02       Impact factor: 3.829

6.  Use of the AUDIT and the DAST-10 to identify alcohol and drug use disorders among adults with a severe and persistent mental illness.

Authors:  S A Maisto; M P Carey; K B Carey; C M Gordon; J R Gleason
Journal:  Psychol Assess       Date:  2000-06

7.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

8.  A descriptive analysis of minor depression.

Authors:  Mark Hyman Rapaport; Lewis L Judd; Pamela J Schettler; Kimberly Ann Yonkers; Michael E Thase; David J Kupfer; Ellen Frank; John M Plewes; Gary D Tollefson; A John Rush
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

9.  Impact of substance disorders on medical expenditures for medicaid beneficiaries with behavioral health disorders.

Authors:  Robin E Clark; Mihail Samnaliev; Mark P McGovern
Journal:  Psychiatr Serv       Date:  2009-01       Impact factor: 3.084

Review 10.  Psychosocial interventions for people with both severe mental illness and substance misuse.

Authors:  M Cleary; G Hunt; S Matheson; N Siegfried; G Walter
Journal:  Cochrane Database Syst Rev       Date:  2008-01-23
View more
  9 in total

1.  Does group cognitive-behavioral therapy module type moderate depression symptom changes in substance abuse treatment clients?

Authors:  Susan M Paddock; Sarah B Hunter; Thomas J Leininger
Journal:  J Subst Abuse Treat       Date:  2014-03-01

2.  Bayesian models for semicontinuous outcomes in rolling admission therapy groups.

Authors:  Lane F Burgette; Susan M Paddock
Journal:  Psychol Methods       Date:  2017-12

3.  Randomized controlled trial of telephone monitoring with psychiatry inpatients with co-occurring substance use and mental health disorders.

Authors:  Christine Timko; Alex H S Harris; Mary Jannausch; Mark Ilgen
Journal:  Drug Alcohol Depend       Date:  2018-10-29       Impact factor: 4.492

4.  Training Addiction Counselors to Implement an Evidence-Based Intervention: Strategies for Increasing Organizational and Provider Acceptance.

Authors:  Stephanie M Woo; Kimberly A Hepner; Elizabeth A Gilbert; Karen Chan Osilla; Sarah B Hunter; Ricardo F Muñoz; Katherine E Watkins
Journal:  Cogn Behav Pract       Date:  2013-05-01

5.  Major depressive disorder and access to health services among people who use illicit drugs in Vancouver, Canada.

Authors:  Tara Beaulieu; Lianping Ti; M-J Milloy; Ekaterina Nosova; Evan Wood; Kanna Hayashi
Journal:  Subst Abuse Treat Prev Policy       Date:  2018-01-19

6.  Healing pathways: a program for women with physical disabilities and depression.

Authors:  Dena Hassouneh; Thuan Nguyen; Zunqiu Chen; Elizabeth McNeff
Journal:  Rehabil Res Pract       Date:  2013-05-02

Review 7.  Treatment of comorbid alcohol use disorders and depression with cognitive-behavioural therapy and motivational interviewing: a meta-analysis.

Authors:  Heleen Riper; Gerhard Andersson; Sarah B Hunter; Jessica de Wit; Matthias Berking; Pim Cuijpers
Journal:  Addiction       Date:  2014-01-16       Impact factor: 6.526

8.  RCT of an integrated CBT-HIV intervention on depressive symptoms and HIV risk.

Authors:  Karin Tobin; Melissa A Davey-Rothwell; Bareng A S Nonyane; Amy Knowlton; Lawrence Wissow; Carl A Latkin
Journal:  PLoS One       Date:  2017-12-14       Impact factor: 3.240

9.  Outcomes of an integrated care pathway for concurrent major depressive and alcohol use disorders: a multisite prospective cohort study.

Authors:  Andriy V Samokhvalov; Charlotte Probst; Saima Awan; Tony P George; Bernard Le Foll; Peter Voore; Jürgen Rehm
Journal:  BMC Psychiatry       Date:  2018-06-13       Impact factor: 3.630

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.